Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane

- Asthma
- Completed

Study Title: Efficacy and Safety Comparison of Albuterol Spiromaxֲ® and ProAirֲ® Hydrofluoroalkane (HFA) in Pediatric Patients

Teva Identifier: ABS-AS-202

ClinicalTrials.gov Identifier: NCT01899144

Study Status: Completed

Trial Condition(s): Asthma

Interventions: Drug: Albuterol Spiromax | Drug: ProAir HFA | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child

Age Range: 4 Years to 11 Years

Trial Duration: 07/01/2013 - 10/01/2013

Phase: Phase 2

Study Type

Interventional